Boston Scientific Launches Clinical Trial Of Innova Peripheral Vascular Drug-Eluting Stent System

Launching a key clinical trial expected to serve as the foundation for global regulatory approvals, a physician in Auckland, New Zealand has performed the first patient implant of the Boston Scientific Corporation (NYSE: BSX ) Innova™ Drug-Eluting Stent (DES) System. The MAJESTIC trial -- designed to evaluate the safety and